Category: Cardiovascular Systems Inc.Syndicate content

Cardiovascular Systems lands FDA win for new Diamondback 360

March 10, 2014 by Arezu Sarvestani

Medtech maker Cardiovascular Systems touts FDA clearance for a 60cm model of its Diamondback 360 peripheral orbital atherectomy system.

Cardiovascular Systems lands FDA win for new Diamondback 360

Minnesota-based Cardiovascular Systems (NSDQ:CSII) landed FDA clearance for a new size of its Diamondback 360 atherectomy system, used in treatment of peripheral artery disease.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems touts 1-year outcomes, cost savings for Diamondback 360

February 25, 2014 by Arezu Sarvestani

Cardiovascular Systems unveils 1-year data from its ORBIT II study, reporting positive safety and efficacy outcomes as well as significant cost-savings for the Diamondback 360 atherectomy device.

Cardiovascular Systems touts 1-year outcomes for Diamondback 360

Minnesota-based Cardiovascular Systems (NSDQ:CSII) this week unveiled 1-year outcomes of a pivotal study of its Diamondback 360 device in treating coronary artery disease.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems surges on Q2 results, outlook

January 30, 2014 by Brad Perriello

Cardiovascular Systems shares surge nearly 20% after the medical device company's 2nd-quarter sales numbers and fiscal 3rd-quarter outlook beat expectations.

Cardiovascular Systems surges on Q2 results, outlook

Cardiovascular Systems (NSDQ:CSII) shares surged nearly 20% today on better-than-expected fiscal 2nd-quarter numbers and a 3rd-quarter outlook that came out well ahead of Wall Street's forecast.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems raises $84.5M through public offering

November 27, 2013 by Arezu Sarvestani

Cardiovascular Systems beats its estimates, raising more than $84 million through an underwritten public offering of its common stock.

Cardiovascular Systems raises $84.5M in common stock

Minnesota medical device maker Cardiovascular Systems (NSDQ:CSII) announced that it raised $84.5 million through sales of 3 million shares of its common stock.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems' public offering could garner $70M

November 19, 2013 by Arezu Sarvestani

Minnesota medical device maker Cardiovascular Systems plans to offer more than 2.1 million shares of its common stock, a potential take of $70 million based on the company's estimates.

Cardiovascular Systems public offering could garner $65M

Cardiovascular Systems (NSDQ:CSII) announced this week an upcoming stock offering worth up to $70 million in net proceeds, according to an early estimate.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems hits 52-week high on Q1 results

October 31, 2013 by Brad Perriello

Shares of Cardiovascular Systems hit a 52-week high after the medical device company beats expectations with its fiscal 1st-quarter results.

Cardiovascular Systems hits 52-week high on Q1 results

Cardiovascular Systems (NSDQ:CSII) shares posted a 52-week high just after noon today as investors reacted to strong fiscal 1st-quarter results.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems jumps 18% on FDA approval

October 22, 2013 by Arezu Sarvestani

Minnesota's Cardiovascular Systems gets a Wall Street boost after winning FDA approval for its Diamondback 360 Coronary Orbital Atherectomy System.

Cardiovascular Systems jumps 18% on FDA approval

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp